On December 29th, 2016, in pursuance of Resolution of the Cabinet of Ministers of Ukraine "On State Regulation of Prices for Medicinal Products" No. 862, the Ministry of Health of Ukraine adopted Order No. 1423, thereby approving the Procedure for Calculating Maximum Gross Wholesale Prices for Medicinal Products on the basis of Reference Prices (hereinafter - the Procedure). The Procedure was officially published and came into force on January 6th, 2017. The Procedure applies to medicinal products used in treatment of cardiovascular diseases, diabetes of type II and bronchial asthma, the cost of which is refundable in accordance with Resolution of the Cabinet of Ministers of Ukraine No. 863 as of November 9th, 2016 (21 INPN in total).
As its name implies, the Procedure establishes a mechanism for calculating maximum gross wholesale prices for medicinal products on the basis of reference prices. The latter are determined in UAH (reference prices in foreign currencies are denominated in UAH at the official NBU rate as of the date of determination of prices), taking into account the data on registered prices for medicinal products (of each dosage form) obtained from official sources of the authorized public authorities of the following reference countries: the Republic of Poland, the Slovak Republic, the Czech Republic, the Republic of Latvia and Hungary.
Maximum gross wholesale price of a single dosage form of a medicinal product from among 21 INPN is calculated as the smallest reference price of a unit of each dosage sample values of the respective reference prices in the countries using the following algorithm:
MGWP = MIN (RP1 ... RPN),
Where MGWP – maximum gross wholesale price;
RP1 RPN - reference prices in the reference countries.
The Ministry of Health of Ukraine is in charge of maintaining the register of maximum gross wholesale prices for medicinal products in electronic form. The Ministry is obliged to publish relevant data in electronic form on its official website (www.moz.gov.ua). However, as of January 27th, 2017 only Order No. 53 as of January 23rd, 2017 of the said Ministry, which approved the register of maximum gross wholesale prices for medicinal products as of January 16th, 2017, was published.
The event focused on the transformation of Ukraine's intellectual property sector on its path toward European integration.
Improving access to safe and affordable medicines for the Ukrainian population is one of the Government of Ukraine's top priorities. SAFEMed Activity (2017-2025) has supported this effort by appIying health system strengthening best practices.
The Ministry of Health website has posted a notice about the release of a revised draft order of the Ministry of Health ‘On Approval of Amendments to Certain Re
On 25 September, a webinar was held on the topic: ‘180 days of new drug price regulation. Results, prospects and practical advice.’ The event was organized by LA Law Firm in partnership with Proxima Research International.
